Références

Information sur le cancer / Types de cancer / Sein / Traitement / Stade 2

American Cancer Society. (2015, June 10). Breast Cancer. Extrait de: http://www.cancer.org/cancer/breastcancer/index.

Brackstone M, Fletcher GG, Dayes IS, Madarnas Y, SenGupta SK, Verma S, and Members of the Breast Cancer Disease Site Group. Locoregional therapy of locally advanced breast cancer: a clinical practice guideline. (2015, March). Current Oncology. 22(S1): S54-S66.

Eisen A, Fletcher GG, Gandhi S, Mates M, Freedman OC, Dent SF, Trudeau ME and members of the Early Breast Cancer Systemic Therapy Consensus Panel. Optimal systemic therapy for early breast cancer in women: a clinical practice guideline. (2015, March). Current Oncology. 22(S1): S67-S81.

Goss, PE, Ingle JN, Pritchard KJ, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. (2016, July 21). New England Journal of Medicine. 175(3): 209-219.

Hoffmann-La Roche Limited. (2018, August 30). Product Monograph: Perjeta.

Morrow M, Burstein HJ, and Harris JR. Malignant tumors of the breast. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 79: 1117-1156.

National Cancer Institute. (2015, July 8). Breast Cancer Treatment for Health Professionals (PDQ®).

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 2.2015). Extrait de: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

×
×